New in treatment of hyperactive bladder with urge urinary incontinence in women
The combination of α1 adrenoceptor blocking agent and phosphodiesterase inhibitor of 5th type is efficient in treatment of women with hyperactive bladder and urge urinary incontinence, which was proved by the studies of urodynamic and microcirculation of mucous coat of bladder.
Saved in:
| Main Authors: | A. I. Neimark, M. V. Razdorskaya, I. V. Snegiryov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Siberian State Medical University (Tomsk)
2012-04-01
|
| Series: | Бюллетень сибирской медицины |
| Subjects: | |
| Online Access: | https://bulletin.ssmu.ru/jour/article/view/461 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Outcomes of Sacral Neuromodulation and Intradetrusor Onabotulinum Toxin in the Management of Stroke Associated Urinary Incontinence
by: Tyler Trump, et al.
Published: (2025-03-01) -
Associations of cigarette use, e-cigarette use, and dual use, with nocturia and urge urinary incontinence in US adults
by: Xiangwei Yang, et al.
Published: (2025-03-01) -
Combination of skin sympathetic nerve activity and urine biomarkers in improving diagnostic accuracy for urge urinary incontinence
by: Yu-Chen Chen, et al.
Published: (2025-04-01) -
The association between urinary BPA concentrations and urinary incontinence in women
by: Qian Lyu, et al.
Published: (2025-05-01) -
Investigating the Risk Indicators of Urinary Incontinence Among Young Nulligravid Women: A Cross-Sectional Study
by: Ghada Mohammed, et al.
Published: (2025-01-01)